{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:08:16Z","timestamp":1780574896464,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anaerobe"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.anaerobe.2023.102764","type":"journal-article","created":{"date-parts":[[2023,7,20]],"date-time":"2023-07-20T00:28:36Z","timestamp":1689812916000},"page":"102764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Biology activity and characterization of the functional L-HN fragment derivative of botulinum neurotoxin serotype E"],"prefix":"10.1016","volume":"82","author":[{"given":"Xiao","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong-Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Sheng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo-Lin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu-Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5124-9688","authenticated-orcid":false,"given":"Yun-Zhou","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anaerobe.2023.102764_bib1","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1128\/IAI.01025-07","article-title":"Subunit vaccine against the seven serotypes of botulism","volume":"76","author":"Baldwin","year":"2008","journal-title":"Infect. Immun."},{"key":"10.1016\/j.anaerobe.2023.102764_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2022.107876","article-title":"Elucidation of critical pH-dependent structural changes in Botulinum Neurotoxin E","volume":"214","author":"Lalaurie","year":"2022","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.anaerobe.2023.102764_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23179620","article-title":"Crystal structures of the Clostridium botulinum neurotoxin A6 cell binding domain alone and in complex with GD1a reveal significant conformational flexibility","volume":"23","author":"Gregory","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.anaerobe.2023.102764_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms10051001","article-title":"Recent developments in botulinum neurotoxins detection","volume":"10","author":"Rasetti-Escargueil","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.anaerobe.2023.102764_bib5","article-title":"Identification and characterization of a novel botulinum neurotoxin","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.anaerobe.2023.102764_bib6","article-title":"Purification and characterization of recombinant botulinum neurotoxin serotype FA, also known as serotype","volume":"10","author":"Hackett","year":"2018","journal-title":"H. Toxins (Basel)"},{"key":"10.1016\/j.anaerobe.2023.102764_bib7","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41598-022-05008-1","article-title":"Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid","volume":"12","author":"Nowakowska","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.anaerobe.2023.102764_bib8","article-title":"Development and evaluation of a tetravalent botulinum vaccine","volume":"18","author":"Shi","year":"2022","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.anaerobe.2023.102764_bib9","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1016\/j.str.2017.09.004","article-title":"Botulinum toxins A and E inflict dynamic destabilization on t-SNARE to impair SNARE assembly and membrane fusion","volume":"25","author":"Khounlo","year":"2017","journal-title":"Structure"},{"key":"10.1016\/j.anaerobe.2023.102764_bib10","volume":"vol. 11","author":"Mechaly","year":"2022"},{"key":"10.1016\/j.anaerobe.2023.102764_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1107\/S1744309110012182","article-title":"Preliminary X-ray crystallographic study of the receptor-binding domain of the D\/C mosaic neurotoxin from Clostridium botulinum","volume":"66","author":"Nuemket","year":"2010","journal-title":"Acta Crystallogr., Sect. F: Struct. Biol. Cryst. Commun."},{"key":"10.1016\/j.anaerobe.2023.102764_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10100421","article-title":"Variations in the botulinum neurotoxin binding domain and the potential for novel therapeutics","volume":"10","author":"Davies","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.anaerobe.2023.102764_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/DSS.0000000000001277","article-title":"Botulinum toxin in aesthetic medicine: myths and realities","volume":"44","author":"Dover","year":"2018","journal-title":"Dermatol. Surg."},{"key":"10.1016\/j.anaerobe.2023.102764_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/s00702-022-02494-5","article-title":"Botulinum toxin therapy: past, present and future developments","volume":"129","author":"Dressler","year":"2022","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.anaerobe.2023.102764_bib15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1128\/IAI.00063-15","article-title":"The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions","volume":"83","author":"Ayyar","year":"2015","journal-title":"Infect. Immun."},{"key":"10.1016\/j.anaerobe.2023.102764_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/toxins10070268","article-title":"Light chain diversity among the botulinum neurotoxins","volume":"10","author":"Gardner","year":"2018","journal-title":"Toxins"},{"key":"10.1016\/j.anaerobe.2023.102764_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jsb.2010.11.010","article-title":"Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B","volume":"174","author":"Masuyer","year":"2011","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.anaerobe.2023.102764_bib18","article-title":"Functional EL-HN fragment as a potent candidate vaccine for the prevention of botulinum neurotoxin serotype","volume":"14","author":"Li","year":"2022","journal-title":"E. Toxins"},{"key":"10.1016\/j.anaerobe.2023.102764_bib19","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1007\/s12640-021-00337-x","article-title":"Recombinant L-HN fusion antigen derived from the L and HN domains of botulinum neurotoxin B stimulates a protective antibody response against","volume":"39","author":"Li","year":"2021","journal-title":"Active Neurotoxin. Neurotox Res."},{"key":"10.1016\/j.anaerobe.2023.102764_bib20","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1016\/j.vaccine.2020.02.060","article-title":"Immunological characterisation and immunoprotective efficacy of functional domain antigens of botulinum neurotoxin serotype A","volume":"38","author":"Liu","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.anaerobe.2023.102764_bib21","doi-asserted-by":"crossref","first-page":"32815","DOI":"10.1074\/jbc.M205258200","article-title":"Botulinum neurotoxin A activity is dependent upon the presence of specific gangliosides in neuroblastoma cells expressing synaptotagmin I","volume":"277","author":"Yowler","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.anaerobe.2023.102764_bib22","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1128\/AAC.00141-09","article-title":"Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A","volume":"53","author":"Roxas-Duncan","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.anaerobe.2023.102764_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz4197","article-title":"Delivery of single-domain antibodies into neurons using a chimeric toxin-based platform is therapeutic in mouse models of botulism","volume":"13","author":"Miyashita","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.anaerobe.2023.102764_bib24","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1091\/mbc.e08-07-0765","article-title":"Glycosylated SV2A and SV2B mediate the entry of botulinum neurotoxin E into neurons","volume":"19","author":"Dong","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.anaerobe.2023.102764_bib25","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.4161\/hv.7.10.16763","article-title":"Binding activity and immunogenic characterization of recombinant C-terminal quarter and half of the heavy chain of botulinum neurotoxin serotype A","volume":"7","author":"Yu","year":"2011","journal-title":"Hum. Vaccine"},{"key":"10.1016\/j.anaerobe.2023.102764_bib26","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.pep.2005.07.020","article-title":"Cloning, expression, and purification of C-terminal quarter of the heavy chain of botulinum neurotoxin type A","volume":"45","author":"Sharma","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.anaerobe.2023.102764_bib27","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science (New York, NY)"},{"key":"10.1016\/j.anaerobe.2023.102764_bib28","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1523\/JNEUROSCI.0375-08.2008","article-title":"Long-distance retrograde effects of botulinum neurotoxin A","volume":"28","author":"Antonucci","year":"2008","journal-title":"J. Neurosci. : Off.J.Soc.Neurosci."},{"key":"10.1016\/j.anaerobe.2023.102764_bib29","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.neuro.2020.02.009","article-title":"Endocytosis, trafficking and exocytosis of intact full-length botulinum neurotoxin type a in cultured rat neurons","volume":"78","author":"Solabre Valois","year":"2020","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.anaerobe.2023.102764_bib30","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/sj.embor.7400796","article-title":"Entering neurons: botulinum toxins and synaptic vesicle recycling","volume":"7","author":"Verderio","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.anaerobe.2023.102764_bib31","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","article-title":"Neurotoxins affecting neuroexocytosis","volume":"80","author":"Schiavo","year":"2000","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.anaerobe.2023.102764_bib32","first-page":"257","article-title":"Progress in cell based assays for botulinum neurotoxin detection","volume":"364","author":"Pellett","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.anaerobe.2023.102764_bib33","article-title":"Antigenic sites on the HN domain of botulinum neurotoxin A stimulate protective antibody responses against active toxin","volume":"5","author":"Ayyar","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.anaerobe.2023.102764_bib34","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1038\/s41598-022-05008-1","article-title":"Construction and validation of safe Clostridium botulinum Group II surrogate strain producing inactive botulinum neurotoxin type E toxoid","volume":"12","author":"Nowakowska","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.anaerobe.2023.102764_bib35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.resmic.2014.10.010","article-title":"Genomes, neurotoxins and biology of Clostridium botulinum Group I and Group II","volume":"166","author":"Carter","year":"2015","journal-title":"Res. Microbiol."},{"key":"10.1016\/j.anaerobe.2023.102764_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S1046-5928(02)00002-5","article-title":"Expression and purification of catalytically active, non-toxic endopeptidase derivatives of Clostridium botulinum toxin type A","volume":"25","author":"Chaddock","year":"2002","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.anaerobe.2023.102764_bib37","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8050154","article-title":"Botulinum neurotoxin serotype A recognizes its protein receptor SV2 by a different mechanism than botulinum neurotoxin B synaptotagmin","volume":"8","author":"Weisemann","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.anaerobe.2023.102764_bib38","first-page":"61","article-title":"Double receptor anchorage of botulinum neurotoxins accounts for their exquisite neurospecificity","volume":"364","author":"Rummel","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.anaerobe.2023.102764_bib39","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1128\/IAI.00057-12","article-title":"Tetanus toxin and botulinum toxin a utilize unique mechanisms to enter neurons of the central nervous system","volume":"80","author":"Blum","year":"2012","journal-title":"Infect. Immun."},{"key":"10.1016\/j.anaerobe.2023.102764_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002008","article-title":"Botulinum neurotoxin D uses synaptic vesicle protein SV2 and gangliosides as receptors","volume":"7","author":"Peng","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.anaerobe.2023.102764_bib41","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0306-4522(99)00370-X","article-title":"SV2C is a synaptic vesicle protein with an unusually restricted localization: anatomy of a synaptic vesicle protein family","volume":"94","author":"Janz","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.anaerobe.2023.102764_bib42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/0092-8674(92)90319-8","article-title":"The synaptic vesicle protein SV2 is a novel type of transmembrane transporter","volume":"70","author":"Feany","year":"1992","journal-title":"Cell"}],"container-title":["Anaerobe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996423000732?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1075996423000732?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:42:38Z","timestamp":1761036158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1075996423000732"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":42,"alternative-id":["S1075996423000732"],"URL":"https:\/\/doi.org\/10.1016\/j.anaerobe.2023.102764","relation":{},"ISSN":["1075-9964"],"issn-type":[{"value":"1075-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biology activity and characterization of the functional L-HN fragment derivative of botulinum neurotoxin serotype E","name":"articletitle","label":"Article Title"},{"value":"Anaerobe","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anaerobe.2023.102764","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102764"}}